Long-Term Effect of Left Atrial Appendage Occlusion in Treating Patients with Previous Ischemic Stroke on the Disease Recurrence

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2021 Oct 25

PMID 34691240

Citations 1

Authors

Jia Yu

Yufeng Liu

Peng Sun

Xing Guo

Haiyang Jiang

Wei Fang

Xin Jin

Affiliations

Soon will be listed here.

Abstract

Methods: A total of 120 patients with IS admitted to Tangdu Hospital from July 2016 to September 2017 were grouped into the control group ( = 60) and the observation group ( = 60). Patients in the control group were only treated with thrombolytics and anticoagulants while those in the observation group were treated with both drugs and LAAO. Transesophageal echocardiography (TEE) was performed to observe the occlusion of LAA in patients in the observation group after 45 d and 6 months, respectively. Clinical outcomes in two groups were compared from the following aspects: recurrence of IS, incidence of systemic embolism, and the 3-year recurrence-free survival (RFS). The 3-year IS recurrence of patients was compared by Fisher's exact test.

Results: No significant differences were observed at baseline levels (age, sex, etc.) between the observation group and control group ( > 0.05). During follow-up visit of 45 d and 6 months, all occluders met the efficacious occludsion criteria. The results of TEE at 45 d after LAAO showed that 50% of patients (30/60) in the observation group had complete occlusion of LAA. The results of TEE at 6 months after LAAO suggested that 58.3% of patients (35/60) had complete occlusion of LAA. IS recurrence in the observation group (3.33%, 2/60) was significantly lower than that in the control group (18.33%, 11/60), with the difference presenting statistical significance ( = 0.008). Incidence of systemic embolism in the observation group (1.67%, 1/60) was markedly lower than that in the control group (13.33%, 11/60) ( = 0.014). The average RFS in the observation group (31.97 months, 95% CI: 27.50~32.31 months) was notably longer than that in the control group (29.91 months, 95% CI: 29.85~32.92 months) ( < 0.05). The 3-year IS recurrence of patients between two groups compared by Fisher's exact test showed significant differences (1 year: = 0.014, 2 year: = 0.008, 3 year: = 0.008).

Conclusion: Regarding patients with previous IS who had poor response to thrombolytics and anticoagulants, LAAO could effectively decrease recurrence of IS and incidence of systemic embolism and prolong RFS of patients. LAAO was, therefore, an alternative for patients with high IS recurrence risk.

Citing Articles

Prediction model based on machine learning for short- and long-term adverse events in left atrial appendage closure.

Zhang X, Tian B, Cong X, Hao S, Huan Q, Jin C J Thorac Dis. 2022; 14(6):2147-2157.

PMID: 35813710 PMC: 9264065. DOI: 10.21037/jtd-22-499.

References

Boersma L, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B . Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2017; 14(9):1302-1308. DOI: 10.1016/j.hrthm.2017.05.038. View

Obel O, Camm A . Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999; 82(5):547-54. PMC: 1760793. DOI: 10.1136/hrt.82.5.547. View

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38):2893-2962. DOI: 10.1093/eurheartj/ehw210. View

Suda S, Nito C, Yokobori S, Sakamoto Y, Nakajima M, Sowa K . Recent Advances in Cell-Based Therapies for Ischemic Stroke. Int J Mol Sci. 2020; 21(18). PMC: 7555943. DOI: 10.3390/ijms21186718. View

Landmesser U, Holmes Jr D . Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation. Eur Heart J. 2011; 33(6):698-704. DOI: 10.1093/eurheartj/ehr393. View

Goldstein L, Bushnell C, Adams R, Appel L, Braun L, Chaturvedi S . Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010; 42(2):517-84. DOI: 10.1161/STR.0b013e3181fcb238. View

Paul S, Candelario-Jalil E . Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Exp Neurol. 2020; 335:113518. PMC: 7869696. DOI: 10.1016/j.expneurol.2020.113518. View

Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P . Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol. 2020; 75(25):3122-3135. DOI: 10.1016/j.jacc.2020.04.067. View

Hutt E, Wazni O, Kaur S, Saliba W, Tarakji K, Kapadia S . Left atrial appendage closure device implantation in patients at very high risk for stroke. Heart Rhythm. 2019; 17(1):27-32. DOI: 10.1016/j.hrthm.2019.07.011. View

10.

Cruz-Gonzalez I, Gonzalez-Ferreiro R, Freixa X, Gafoor S, Shakir S, Omran H . Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry. Rev Esp Cardiol (Engl Ed). 2019; 73(1):28-34. DOI: 10.1016/j.rec.2019.02.013. View

11.

Fink T, Vogler J, Heeger C, Sano M, Sciacca V, Reissmann B . Impact of Left Atrial Appendage Closure on LAA Thrombus Formation and Thromboembolism After LAA Isolation. JACC Clin Electrophysiol. 2020; 6(13):1687-1697. DOI: 10.1016/j.jacep.2020.07.003. View

12.

Kwon H, Lee D, Lee M, Yu S, Lim J, Yu K . Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study. J Neurol. 2019; 267(3):688-693. DOI: 10.1007/s00415-019-09630-4. View

13.

Hanif H, Belley-Cote E, Alotaibi A, Dvirnik N, Neupane B, Beyene J . Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino). 2017; 59(1):128-139. DOI: 10.23736/S0021-9509.17.09824-X. View

14.

Li Q, Zhao Z, Si K, Zhou J, Du L, Liu H . Correlation between the levels of NLRP3, Hcy, IL-1β, IL-18 and the prognosis in patients with hemorrhagic stroke. Am J Transl Res. 2021; 13(4):2883-2890. PMC: 8129339. View

15.

Khanevski A, Bjerkreim A, Novotny V, Naess H, Thomassen L, Logallo N . Recurrent ischemic stroke: Incidence, predictors, and impact on mortality. Acta Neurol Scand. 2019; 140(1):3-8. PMC: 6594196. DOI: 10.1111/ane.13093. View

16.

Arboix A . Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases. 2015; 3(5):418-29. PMC: 4419105. DOI: 10.12998/wjcc.v3.i5.418. View

17.

Wu X, Fan D, Huang W, Meng Y, Wan T, Amsterdam E . Contrast-enhanced transesophageal echocardiography predicts neo-intimal coverage of device post-left atrial appendage closure. Cardiol J. 2020; 29(3):489-498. PMC: 9170315. DOI: 10.5603/CJ.a2020.0125. View

18.

Wang Y, Liu M, Pu C . 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack. Int J Stroke. 2017; 12(3):302-320. DOI: 10.1177/1747493017694391. View

19.

Ojo A, Yandrapalli S, Veseli G, Karim M, Aronow W, Sharma M . Left Atrial Appendage Occlusion in the Management of Stroke in Patients With Atrial Fibrillation. Cardiol Rev. 2018; 28(1):42-51. DOI: 10.1097/CRD.0000000000000240. View

20.

Pan Y, Zhang L, Li Z, Meng X, Wang Y, Li H . Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China. Stroke. 2020; 51(4):1265-1271. DOI: 10.1161/STROKEAHA.119.027980. View